Sagentia Selected As Development Partner For Set Point Medicall’s Novel Neuromodulation Device To Treat Chronic Inflammatory Diseases

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Sagentia, a global technology and product development company, has been hired by SetPoint Medical to work on the development of the programming interface for a neuromodulation device. The device aims to provide patients with a lower risk and lower cost alternative to immunosuppressive drugs for the treatment of chronic inflammatory diseases.

Help employers find you! Check out all the jobs and post your resume.

Back to news